These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 390660)

  • 21. [Levamisole - attempts at pharmacological immunostimulation].
    Pawłowska EM
    Pol Tyg Lek; 1979 Oct; 34(42):1649-50. PubMed ID: 316134
    [No Abstract]   [Full Text] [Related]  

  • 22. Study of lymphocyte subpopulations in patients with systemic lupus erythematosus. In vitro effect of levamisole on T-lymphocyte population.
    Pozsonyi T; Jakab L; Fehér J
    Allergol Immunopathol (Madr); 1980; 8(5):553-8. PubMed ID: 6970515
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of Levamisole on peripheral blood lymphocyte subpopulations in patients with rheumatoid arthritis and ankylosing spondylitis.
    Rosenthal M; Trabert U; Müller W
    Clin Exp Immunol; 1976 Sep; 25(3):493-6. PubMed ID: 1085681
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Letter: Levamisole.
    Lancet; 1975 Mar; 1(7906):574-5. PubMed ID: 47045
    [No Abstract]   [Full Text] [Related]  

  • 25. Immunomodulators--thymus factor X (TFX) and levamisole in immune reactions and inflammatory processes.
    Giełdanowski J
    Arch Immunol Ther Exp (Warsz); 1981; 29(2):121-32. PubMed ID: 7305628
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Levamisole - a new immunostimulant].
    Rachkov SM
    Ter Arkh; 1976; 48(11):133-8. PubMed ID: 1088219
    [No Abstract]   [Full Text] [Related]  

  • 27. Levamisole, an anti-anergic chemotherapeutic agent: experimental and clinical findings.
    Hobeke J
    Adv Exp Med Biol; 1976; 73 PT-A():422-4. PubMed ID: 998417
    [No Abstract]   [Full Text] [Related]  

  • 28. Cytotoxic T-cell-mediated antitumor effect of levamisole against murine syngeneic fibrosarcoma.
    Gomi K; Morimoto M; Nomoto K
    Cancer Res; 1982 Oct; 42(10):4197-202. PubMed ID: 6980702
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunomodulating activity of 3-(p-chlorophenyl)thiazolo-[3,2-a] benzimidazole-2-acetic acid (Wy-18,251, NSC 310633) in mice implanted with Lewis lung tumor. Effect of Wy-18,251 on lymphocyte proliferation and phagocytosis.
    Fenichel RL; Dheer SK; Grant NH; Scott DP; Bloom R; Gregory FJ
    J Immunopharmacol; 1983; 5(4):333-40. PubMed ID: 6607960
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Immunomodulator in the study of rheumatoid arthritis (author's transl)].
    Abe S
    Ryumachi; 1978 Dec; 18(6):381-4. PubMed ID: 375429
    [No Abstract]   [Full Text] [Related]  

  • 31. Adjuvant treatment with levamisole in cancer: a review of experimental and clinical data.
    Amery WK; Spreafico F; Rojas AF; Denissen E; Chirigos M
    Cancer Treat Rev; 1977 Sep; 4(3):167-94. PubMed ID: 589606
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Immunomodulating action of levamisol preparation in the treatment of trichinellosis (author's transl)].
    Szadkowska D; Boroń P; Borzuchowska A; Prokopowicz D; Boroń-Kaczmarska A
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1981 Dec; 251(2):273-8. PubMed ID: 6978586
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Angioimmunoblastic lymphadenopathy treated by levamisole].
    Youinou P; Andrieu JM; Herzog C
    Nouv Presse Med; 1979 Feb; 8(6):444. PubMed ID: 317971
    [No Abstract]   [Full Text] [Related]  

  • 34. [Experimental study on levamisole modulation of antitumor immunity--1].
    Saji S; Ooshita H; Adachi Y; Yamamoto S; Takekoshi T; Sakata K
    Gan To Kagaku Ryoho; 1982 Aug; 9(8):1418-26. PubMed ID: 6985198
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of levamisole on malignant experimental neurinoma grown subcutaneously in a young rat: brief communication.
    Aleksic S; Drnovski F; Bloom A; Rappaport H; Ransohoff J
    J Natl Cancer Inst; 1977 Nov; 59(5):1567-7. PubMed ID: 909113
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Levamisole in the modulation of the immune response: the current experimental and clinical state.
    Symoens J; Rosenthal M
    J Reticuloendothel Soc; 1977 Mar; 21(3):175-221. PubMed ID: 142150
    [No Abstract]   [Full Text] [Related]  

  • 37. [Prediction of the effectiveness of levamisole immunotherapy by the sensitivity of blood lymphocytes to the drug].
    Giulling EV; Kravchuk GP; Kazirchuk VE; Maksiuk LV; Zabolotnyĭ DI
    Vrach Delo; 1984 Nov; (11):38-42. PubMed ID: 6335615
    [No Abstract]   [Full Text] [Related]  

  • 38. [Cellular and humoral indicators of the immunomodulating effect of levamisole in patients with lymphocytic leukemia].
    Tretiak NN; Koval' AI; Minchenko ZhN; Sverstiuk AE
    Vrach Delo; 1985 Dec; (12):58-61. PubMed ID: 3879409
    [No Abstract]   [Full Text] [Related]  

  • 39. Influence of surgical removal and effect of levamisole on cytotoxic T-cell-mediated antitumor immunity in mice.
    Gomi K; Morimoto M; Nomoto K
    Cancer Res; 1983 Nov; 43(11):5120-5. PubMed ID: 6604572
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunocompetent cells and lymphocyte reactivity to mitogens in levamisole-treated brain tumor children.
    Hajnzić TF; Kastelan M; Lukac J; Hajnzić T
    Pediatr Hematol Oncol; 1999; 16(4):335-40. PubMed ID: 10407870
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.